why choose us

First received: May 22, 2023

Clinical Trial: MESNA Injection for TMJ Internal Derangement

Study Status: Completed

Recruit Status: RECRUITING

Condition: TMJ Disorder

Study Type: INTERVENTIONAL


Official Title: Treatment of Temporomandibular Joint Internal Derangement Using MESNA Injection

Brief Summary: The pathogenesis of temporomandibular disorders focusing on the biochemistry of the synovial fluid in various stages of temporomandibular joint disease.The role of inflammation has been investigated and proposed as an underlying mechanism of pain and dysfunction of temporomandibular joint.MESNA (sodium 2-mercaptoethanesulfonate) was approved several years ago and marketed in several formulations as a mucolytic agent in the respiratory field, since it breaks the disulfide bonds between polypeptide chains of…

Read more